Table 2.
Variables | Recurrence-free survival | ||||||
---|---|---|---|---|---|---|---|
Patients (n=212) | No. of event | MST (month) | HR (95%CI) | Crude P value | HR (95%CI) | Adjusted P valueѰ | |
HLA-A | |||||||
Low expression | 106 | 61 | 35.20 | Ref. | Ref. | ||
High expression | 106 | 55 | 51.60 | 0.780 (0.542-1.123) | 0.182 | 0.638 (0.439-0.930) | 0.019 |
HLA-B | |||||||
Low expression | 106 | 58 | 43.20 | Ref. | Ref. | ||
High expression | 106 | 58 | 45.90 | 0.989 (0.687-1.424) | 0.954 | 1.105 (0.764-1.598) | 0.597 |
HLA-C | |||||||
Low expression | 106 | 67 | 30.7 | Ref. | Ref. | ||
High expression | 106 | 49 | 57.9 | 0.649 (0.448-0.938) | 0.022 | 0.664 (0.458-0.963) | 0.031 |
HLA-DMA | |||||||
Low expression | 106 | 61 | 40.4 | Ref. | Ref. | ||
High expression | 106 | 55 | 49.1 | 0.894 (0.621-1.287) | 0.545 | 0.923 (0.640-1.332) | 0.669 |
HLA-DMB | |||||||
Low expression | 106 | 52 | 53.0 | Ref. | Ref. | ||
High expression | 106 | 64 | 29.9 | 1.387 (0.962-2.001) | 0.080 | 1.378 (0.943-2.015) | 0.098 |
HLA-DOA | |||||||
Low expression | 106 | 60 | 36.0 | Ref. | Ref. | ||
High expression | 106 | 56 | 51.1 | 0.906 (0.629-1.305) | 0.596 | 0.894 (0.617-1.294) | 0.553 |
HLA-DOB | |||||||
Low expression | 106 | 56 | 51.1 | Ref. | Ref. | ||
High expression | 106 | 60 | 37.9 | 1.179 (0.819-1.697) | 0.376 | 1.116 (0.772-1.615) | 0.559 |
HLA-DPA1 | |||||||
Low expression | 106 | 63 | 36.6 | Ref. | Ref. | ||
High expression | 106 | 53 | 53.3 | 0.795 (0.552-1.146) | 0.219 | 0.673 (0.462-0.982) | 0.040 |
HLA-DPB1 | |||||||
Low expression | 106 | 57 | 49.1 | Ref. | Ref. | ||
High expression | 106 | 59 | 30.9 | 1.236 (0.858-1.779) | 0.255 | 1.257 (0.860-1.837) | 0.237 |
HLA-DQA1 | |||||||
Low expression | 106 | 61 | 40.4 | Ref. | Ref. | ||
High expression | 106 | 55 | 53.3 | 0.887 (0.616-1.277) | 0.518 | 0.658 (0.451-0.960) | 0.030 |
HLA-DQB1 | |||||||
Low expression | 106 | 61 | 46.3 | Ref. | Ref. | ||
High expression | 106 | 55 | 40.4 | 0.948 (0.658-1.365) | 0.772 | 1.009 (0.699-1.458) | 0.960 |
HLA-DQB2 | |||||||
Low expression | 106 | 55 | 46.3 | Ref. | Ref. | ||
High expression | 106 | 61 | 37.9 | 1.164 (0.809-1.676) | 0.413 | 1.202 (0.833-1.735) | 0.324 |
HLA-DRA | |||||||
Low expression | 106 | 60 | 37.9 | Ref. | Ref. | ||
High expression | 106 | 56 | 51.1 | 0.851 (0.591-1.226) | 0.386 | 0.786 (0.541-1.141) | 0.206 |
HLA-DRB1 | |||||||
Low expression | 106 | 57 | 46.3 | Ref. | Ref. | ||
High expression | 106 | 59 | 41.6 | 1.000 (0.695-1.440) | 0.998 | 0.937 (0.635-1.380) | 0.740 |
HLA-DRB4 | |||||||
Low expression | 106 | 58 | 32.7 | Ref. | Ref. | ||
High expression | 106 | 58 | 49.1 | 0.992 (0.689-1.429) | 0.967 | 0.952 (0.659-1.374) | 0.793 |
HLA-DRB6 | |||||||
Low expression | 106 | 59 | 43.2 | Ref. | Ref. | ||
High expression | 106 | 57 | 46.1 | 0.943 (0.655-1.357) | 0.753 | 1.006 (0.696-1.453) | 0.975 |
HLA-E | |||||||
Low expression | 106 | 57 | 41.6 | Ref. | Ref. | ||
High expression | 106 | 59 | 46.1 | 0.999 (0.694-1.439) | 0.997 | 1.087 (0.745-1.585) | 0.667 |
HLA-F | |||||||
Low expression | 106 | 62 | 28.7 | Ref. | Ref. | ||
High expression | 106 | 54 | 53.0 | 0.736 (0.511-1.061) | 0.100 | 0.706 (0.488-1.021) | 0.064 |
HLA-G | |||||||
Low expression | 106 | 60 | 37.9 | Ref. | Ref. | ||
High expression | 106 | 56 | 46.3 | 0.933 (0.648-1.343) | 0.708 | 1.042 (0.717-1.514) | 0.831 |
Note: Ѱ: P values were adjusted for gender, cirrhosis and BCLC stage.